格隆汇12月20日丨金斯瑞生物科技(01548.HK)公布,有关公司的间接非全资附属公司 Probio TechnologyLimited ("Probio Cayman")A 轮融资以及公司认购 Probio Cayman 发行的可转换债券。于2024年12月20日,根据日期为2021年8月24日的可转换债券文书(经日期于2024年12月18日的修订协议修订),公司行使其权利,将7000万美元的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.